TY - JOUR
T1 - Teratogenic effects of pyridoxine on the spinal cord and dorsal root ganglia of embryonic chickens
AU - Sharp, A. A.
AU - Fedorovich, Y.
N1 - Funding Information:
The authors would like to thank Robin Michaels and Maureen Doran for technical assistance. This work was supported by the National Institutes for Health (1 R03 HD039241 to A.A.S.) and the Southern Illinois University School of Medicine. Y.F. was supported by a Saluki Scholars Research Opportunity fellowship through the Southern Illinois University Honors Program.
Publisher Copyright:
© 2015 IBRO.
PY - 2015/3/9
Y1 - 2015/3/9
N2 - Our understanding of the role of somatosensory feedback in regulating motility during chicken embryogenesis and fetal development in general has been hampered by the lack of an approach to selectively alter specific sensory modalities. In adult mammals, pyridoxine overdose has been shown to cause a peripheral sensory neuropathy characterized by a loss of both muscle and cutaneous afferents, but predominated by a loss of proprioception. We have begun to explore the sensitivity of the nervous system in chicken embryos to the application of pyridoxine on embryonic days 7 and 8, after sensory neurons in the lumbosacral region become post-mitotic. Upon examination of the spinal cord, dorsal root ganglion and peripheral nerves, we find that pyridoxine causes a loss of neurotrophic tyrosine kinase receptor type 3-positive neurons, a decrease in the diameter of the muscle innervating nerve tibialis, and a reduction in the number of large diameter axons in this nerve. However, we found no change in the number of Substance P or calcitonin gene-related peptide-positive neurons, the number of motor neurons or the diameter or axonal composition of the femoral cutaneous nerve. Therefore, pyridoxine causes a peripheral sensory neuropathy in embryonic chickens largely consistent with its effects in adult mammals. However, the lesion may be more restricted to proprioception in the chicken embryo. Therefore, pyridoxine lesion induced during embryogenesis in the chicken embryo can be used to assess how the loss of sensation, largely proprioception, alters spontaneous embryonic motility and subsequent motor development.
AB - Our understanding of the role of somatosensory feedback in regulating motility during chicken embryogenesis and fetal development in general has been hampered by the lack of an approach to selectively alter specific sensory modalities. In adult mammals, pyridoxine overdose has been shown to cause a peripheral sensory neuropathy characterized by a loss of both muscle and cutaneous afferents, but predominated by a loss of proprioception. We have begun to explore the sensitivity of the nervous system in chicken embryos to the application of pyridoxine on embryonic days 7 and 8, after sensory neurons in the lumbosacral region become post-mitotic. Upon examination of the spinal cord, dorsal root ganglion and peripheral nerves, we find that pyridoxine causes a loss of neurotrophic tyrosine kinase receptor type 3-positive neurons, a decrease in the diameter of the muscle innervating nerve tibialis, and a reduction in the number of large diameter axons in this nerve. However, we found no change in the number of Substance P or calcitonin gene-related peptide-positive neurons, the number of motor neurons or the diameter or axonal composition of the femoral cutaneous nerve. Therefore, pyridoxine causes a peripheral sensory neuropathy in embryonic chickens largely consistent with its effects in adult mammals. However, the lesion may be more restricted to proprioception in the chicken embryo. Therefore, pyridoxine lesion induced during embryogenesis in the chicken embryo can be used to assess how the loss of sensation, largely proprioception, alters spontaneous embryonic motility and subsequent motor development.
KW - Chicken embryo
KW - DRG
KW - Motor neurons
KW - Proprioception
KW - Pyridoxine
KW - TrkC
UR - http://www.scopus.com/inward/record.url?scp=84921930023&partnerID=8YFLogxK
U2 - 10.1016/j.neuroscience.2014.12.067
DO - 10.1016/j.neuroscience.2014.12.067
M3 - Article
C2 - 25592428
AN - SCOPUS:84921930023
SN - 0306-4522
VL - 289
SP - 233
EP - 241
JO - Neuroscience
JF - Neuroscience
ER -